Adverse events (acute complication after surgery)
It is very uncertain whether suprapubic catheterisation changes adverse events (acute complication after surgery) compared with intermittent self‐catheterisation (very low certainty).
1 finding from 1 review
Discontinuation of medication due to adverse events · adults with renal vasculitis for maintenance therapy
Antibiotics showed no clear difference in adverse events causing study drug discontinuation compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with quiescent ulcerative colitis
It is very uncertain whether probiotic + 5‐aminosalicylic acid (5‐ASA) (mesalazine) changes withdrawal due to adverse events (12 to 52 weeks) compared with 5‐ASA (mesalazine) (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events: number of moderate adverse events · adults and children with cystic fibrosis and P aeruginosa
The intervention showed no clear difference in adverse events: number of moderate adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events associated with PET ‐ not reported · Individuals with Hodgkin lymphoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Allergic reaction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Intervention not reported
Adverse events associated with RAT — not measured · Workers in positions with safety‐sensitive functions, other than commercial drivers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events related to taking of blood samples · children aged 6 to 12 years
1 finding from 1 review
Serious adverse events Duration 3 days to 3 weeks · acute asthma exacerbation
Antibiotics showed no clear difference in serious adverse events Duration 3 days to 3 weeks compared with placebo or usual care (low certainty).
1 finding from 1 review
Adverse events: miscarriaged Ultrasound 12 months · women with submucous fibroids and otherwise unexplained subfertility
It is very uncertain whether operative hysteroscopy changes adverse events: miscarriaged Ultrasound 12 months compared with control (very low certainty).
1 finding from 1 review
Any drug‐related adverse events (CTCAE grade ≥ 2)
Daikenchuto showed no clear difference in any drug‐related adverse events (CTCAE grade ≥ 2) compared with control (low certainty).
1 finding from 1 review
Non‐serious adverse events assessed using ICH‐GCP · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…
It is very uncertain whether L‐ornithine L‐aspartate changes non‐serious adverse events assessed using ICH‐GCP compared with lactulose (very low certainty).
1 finding from 1 review
Non‐serious adverse events assessed using ICH‐GCP · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐serious adverse events assessed using ICH‐GCP · people with cirrhosis who had minimal or overt hepatic encephalopathy or who were at risk for developing hepatic encephalopathy;…
It is very uncertain whether L‐ornithine L‐aspartate changes non‐serious adverse events assessed using ICH‐GCP compared with rifaximin (very low certainty).
1 finding from 1 review
Non‐serious adverse events assessed using ICH‐GCP
It is very uncertain whether L‐ornithine L aspartate changes non‐serious adverse events assessed using ICH‐GCP compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Any adverse events (During ED/hospital admission) · adults and children with acute exacerbation of asthma
1 finding from 1 review
Adverse reaction: cardiac arrest Number of events · neonates receiving EBT
1 finding from 1 review
Adverse events: chlorhexidine versus hydrocolloid · people with burns
It is very uncertain whether chlorhexidine changes adverse events: chlorhexidine versus hydrocolloid compared with non‐antibacterial (very low certainty).
1 finding from 1 review
Investigator‐assessed adverse events (short‐term) · people with acne scars
The review found no eligible studies for this question.
1 finding from 1 review
Investigator‐assessed adverse events (short‐term) · people with acne scars
The review found no eligible studies for this question.
1 finding from 1 review